International Clinical Trial: An 8-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Human Clinical Trial to Evaluate the Functional Efficacy and Safety of Brewer's Yeast Beta-Glucan for Enhancing Immune Function

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (KCT0012104) titled 'An 8-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Human Clinical Trial to Evaluate the Functional Efficacy and Safety of Brewer's Yeast Beta-Glucan for Enhancing Immune Function' on June 9.

Study Type: Interventional Study

Study Design: Primary Purpose : Other(Health Functional Food), Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: Fine BS

Condition:

Diseases of the respiratory system

Intervention: Dietary Supplement : Subjects will be randomly assigned to one of two study groups and will orally take two caps...